Skip to main content

Boston Scientific Adds Directors

Kristina Johnson and Nancy-Ann DeParle are joining the board.

Boston Scientific

(BSX)

just recently

completed the takeover of fellow medical-device maker Guidant, and now the Natick, Mass., company has brought over two of its board members.

Kristina Johnson and Nancy-Ann DeParle were elected as directors Monday, taking Boston Scientific's board member count to 14 from 12.

"We are very pleased to welcome Kristina and Nancy-Ann to Boston Scientific," Pete Nicholas, the chairman of Boston's board, said Wednesday. "Their leadership, intellect and years of experience will be extremely valuable to our company, especially as we begin our combination with Guidant."

Johnson is currently the dean of the Pratt School of Engineering at Duke University. DeParle is a senior adviser for JPMorgan Partners and an adjunct professor at the University of Pennsylvania's Wharton School. DeParle is also a director of

Cerner

(CERN)

,

DaVita

(DVA)

and

Triad Hospitals

(TRI)

.

Boston Scientific won Guidant early this year in a battle with health care giant

Johnson & Johnson

(JNJ)

after J&J refused to match or top its $80-a-share bid.

Shares of Boston Scientific were up 53 cents, or 2.4%, to $22.97.